Cytokines affect procathepsin D-stimulated proliferation of breast cancer cells

Anticancer Research

Volumn 22, Issue 2 A, 2002, Pages 913-919

  Voburka, Zdenek ^a   Vetvicka, Vaclav ^a   Vetvickova, Jana ^a   Fusek, Martin ^a  

^a University of Louisville School of Medicine   (United States)

Author keywords

Breast; Cancer; Cytokines; Procathepsin D; Proliferation

Indexed keywords

ENZYME; PROCATHEPSIN D; RECOMBINANT INTERLEUKIN 10; RECOMBINANT INTERLEUKIN 13; RECOMBINANT INTERLEUKIN 4; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; ARTICLE; BREAST CARCINOGENESIS; BREAST CELL; CANCER CELL CULTURE; CANCER IMMUNOTHERAPY; CELL INFILTRATION; CELL PROLIFERATION; CONTROLLED STUDY; CYTOKINE RELEASE; ENZYME ACTIVATION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN SYNTHESIS; WESTERN BLOTTING;

BREAST NEOPLASMS; CATHEPSIN D; CELL DIVISION; ENZYME PRECURSORS; HUMANS; INTERLEUKIN-10; INTERLEUKIN-13; INTERLEUKIN-4; INTERLEUKINS; RECEPTORS, ESTROGEN; TUMOR CELLS, CULTURED;

EID: 0036249870     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (45)

1. Cathepsin D in breast cancer. A tissue marker associated with metastasis
2. Increased cathepsin D level in the serum of patients with metastatic breast carcinoma detected with a specific procathepsin D immunoassay
3. Humoral immune responses to cathepsin D and glucose-regulated protein 78 in ovarian cancer patiens
4. Modulation of proliferation and chemosensitivity by procathepsin D and its peptides in ovarian cancer
5. Cathepsin D in cancer metastasis. A protease and a ligand
6. Progesterone and estrogen control of rates of synthesis of uterine cathepsin D
7. A secretion of glycoprotein induced by estrogens in human breast cancer cell line
8. Cathepsin D gene is controlled by a mixed promoter, and estrogens stimulate only TATA-dependent transcription in breast cancer cells
9. Characterization of the proximal estrogen-responsive element of human cathepsin D gene
10. Increased secretion, altered processing and glycosilation of pro-cathepsin D in human mammary cancer cells
11. Endocytosis of pro-cathepsin D into breast cancer cells is mostly independent of mannose-6-phosphate receptors
12. Analysis of the interaction of procathepsin D activation peptide with breast cancer cells
13. Role of procathepsin D activation peptide in prostate cancer growth
14. Cathepsin D in breast cancer: Mechanisms and clinical application, a 1999 overview
15. Effect of human procathepsin D on proliferation of human cell lines
16. Mitogenic function of human procathepsin D-role of the activation peptide
17. Anti-human procathepsin D activation peptide antibodies inhibit breast cancer development
18. High incidence of interleukin 10 mRNA but not interleukin 2 mRNA detected in human breast tumours
19. Expression of high-affinity IL-4 receptors on human melanoma, ovarian and breast carcinoma cells
20. Interleukin-4 and interleukin-13 inhibit estrogen-induced breast cancer cell proliferation and stimulate GCDFP-15 expression in human breast cancer cells
21. Inhibition of proliferation and clonal growth of human breast cancer cells by interleukin 13
22. Changes in cytokines and thyroid function in patients with recurrent breast cancer
23. Soluble cytokine receptors: Novel immunotherapeutic agents
24. IL-10 synergizes with IL-4 and IL-3 in inhibiting lysosomal enzyme secretion by human monocytes and lamina propria mononuclear cells from patients with inflammatory bowel disease
25. IFN-gamma increases cathepsin H mRNA levels in mouse macrophages
26. Cleavage of structrural proteins during the assembly of the head of bacteriophage T4
27. Development of gel staining techniques for detecting the secretion of procathepsin D (52-kDa protein) in MCF-7 human breast cancer cells
28. Estrogen-induced lysosomal proteases secreted by breast cancer cells: A role in carcinogenesis
29. Expression of cytokine messenger RNA in normal and neoplastic human breast tissue: Identification of interleukin-8 as a potential regulatory factor in breast tumours
30. In situ cytokine production by breast cancer tumor-infiltrating lymphocytes
31. Receptors for interleukin-13 and interleukin-4 are complex and share a novel component that functions in signal transduction
32. Human breast carcinoma cells express type II IL-4 receptors and are sensitive to antitumor activity of a chimeric IL-4-Pseudomonas exotoxin fusion protein in vitro and in vivo
33. Molecular expression analysis of restrictive receptor for interleukin 13, a brain tumor-associated cancer/testis antigen
34. Human ovarian-carcinoma cell lines express IL-4 and IL-13 receptors: Comparison between IL-40 and IL-13-induced signal transduction
35. Cytokine variations in patients with hormone treated prostate cancer
36. IL-10 and sIL-2R serum levels as possible peripheral blood prognostic markers in the passage from adenoma to colorectal cancer
37. Structure, function, and targeting of interleukin 4 receptors on human head and neck cancer cells
38. Regulatory, effect of interleukin-4 and interleukin-13 on colon cancer cell adhesion
39. Serum IL-10 and IL-13 concentrations in patients with haematological malignancies
40. Interleukin-4 and interleukin-13 inhibit estrogen-induced breast cancer cell proliferation and stimulate GCDFP-15 expression in human breast cancer cells
41. Inhibition of proliferation and clonal growth of human breast cancer cells by interleukin 13
42. Interleukin 4 inhibits growth and induces apoptosis in human breast cancer cells
43. IL-4, IL-10 and IL-13 in acute myelogenous leukemia
44. F. Interleukin (IL)-10, but not IL-4 or IL-13, inhibits cytokine production and growth in juvenile myelomonocytic leukemia cells